Dr. James J. Mancuso, MD

Dr. Mancuso practices at 39385 Methodist Hospital - Op Card 1 - Cardiology - Cardiology - HOPD in San Antonio, Texas.

Dr. Mancuso's NPI, 1134303035, was assigned on December 27, 2007. Dr. Mancuso graduated from Joe R. & Teresa Lozano Long School of Medicine in 2005. Dr. Mancuso holds Texas license N2181.

Dr. Mancuso's primary practice is 39385 Methodist Hospital - Op Card 1 - Cardiology - Cardiology - HOPD, at 4411 Medical Dr, San Antonio, TX 78229.

Dr. Mancuso's primary practice is 39385 Methodist Hospital - Op Card 1 - Cardiology - Cardiology - HOPD in San Antonio, Texas. Dr. Mancuso is also affiliated with Methodist Hospital. The medical group on file is Cardiology Clinic of San Antonio. Dmand AI also links Dr. Mancuso to 1 more hospital, 2 group practices and clinics, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mancuso practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Mancuso's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Mancuso is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Mancuso is licensed in Texas.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Mancuso treats.

CMS data shows 4,111 Medicare services from Dr. Mancuso across 21 procedure codes in 2024, for 1,477 Medicare patients. Medicare paid $202,050 for them.

CMS counts 1,477 Medicare patients who saw Dr. Mancuso in 2024. The largest group is 75 to 84, with 584 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mancuso's median patient age at 72, with 51% women.

In 2024, Dr. Mancuso wrote 1,744 Medicare Part D claims for 339 patients. 78% of them were for generic drugs. CMS names the drug for 1,614 of them, across 26 drugs with 11 or more claims each, at $441,577 in total drug cost. In 2023, CMS named 1,797 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mancuso for performance year 2024, reported individually. Dr. Mancuso accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mancuso as offering telehealth. CMS counts 21 procedures of coronary angioplasty and stenting by Dr. Mancuso, more than 52% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 28 papers to Dr. Mancuso, published from 2002 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Tomography, Optical Coherence, Mice, Inbred C57BL and Neurons. Dr. Mancuso has published most often in J Biomed Opt. Dr. Mancuso's most frequent co-authors are Marc D. Feldman, MD, James Allison, MD and Gustavo C. Roman, MD.

CMS Open Payments shows 555 general payments to Dr. Mancuso from 50 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. Boston Scientific Corporation paid the most, $4,431.

Dmand AI lists 1 award for Dr. Mancuso, most recently CMS Stage 1 EHR in 2013.

Dr. Mancuso graduated from Joe R. & Teresa Lozano Long School of Medicine in 2005. Dr. Mancuso is a member of ACC.

Dr. Mancuso is in network with 23 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.